drugset / Trial / NCT01082146
RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE
NaSingle-groupOpen-label
Summary
This will be an open-label, non-randomized, absorption, metabolism, and excretion study of Lurasidone administered in a suspension at 40 mg to 6 normal healthy male subjects in a postprandial state
Timeline
- Start
- 2008-08
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 40 mg | Oral |
Indications
No indication recorded.